Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Anondita Medicare Ltd
Your Vote -
Buy
33.33%
Hold
0.00%
Sell
66.67%
33.33%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
44%
Sell Order Quantity
56%
Bid Price
Qty
1200.05
200
1200.00
200
1195.00
200
1193.00
200
1192.00
200
Bid Total
9400
Bid Price
Qty
1210.00
200
1219.00
200
1225.00
200
1230.00
200
1235.00
200
Bid Total
11800
Option Chain
Analyzes market sentiment, predicts Anondita Medicare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Anondita Medicare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Anondita Medicare - Amendment to AOA/MOA
-
Anondita Medicare - Shareholders meeting
-
Anondita Medicare - Press Release
-
Anondita Medicare - Bagging/Receiving of orders/contracts
-
Anondita Medicare - Shareholders meeting
-
Anondita Medicare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Anondita Medicare - Bagging/Receiving of orders/contracts
-
Anondita Medicare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Anondita Medicare - Credit Rating- New
-
Anondita Medicare - Investor Presentation
-
Anondita Medicare - Disclosure under SEBI Takeover Regulations
-
Anondita Medicare - Bagging/Receiving of orders/contracts
-
Anondita Medicare - Press Release
-
Anondita Medicare - Corrigendum
-
Anondita Medicare - Integrated Filing- Financial
-
Anondita Medicare - Statement of deviation(s) or variation(s) under Reg. 32
-
Anondita Medicare - Updates
-
Anondita Medicare - Outcome of Board Meeting
-
Anondita Medicare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Anondita Medicare - Copy of Newspaper Publication
-
Anondita Medicare - Corrigendum
-
Anondita Medicare - Monitoring Agency Report
-
Anondita Medicare - Press Release
-
Anondita Medicare - Updates
-
Anondita Medicare - Copy of Newspaper Publication
-
Anondita Medicare - Shareholders meeting
-
Anondita Medicare - Copy of Newspaper Publication
-
Anondita Medicare - Outcome of Board Meeting
-
Anondita Medicare - Preferential issue
-
Anondita Medicare - Issue of Securities
-
Anondita Medicare - Amendment to AOA/MOA
-
Anondita Medicare - Preferential issue
-
Anondita Medicare - Outcome of Board Meeting
-
Anondita Medicare - Press Release
-
Anondita Medicare - Press Release
-
Anondita Medicare - Updates
-
Anondita Medicare - Updates
-
Anondita Medicare - Updates
-
Anondita Medicare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Anondita Medicare - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Anondita Medicare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Anondita Medicare - Updates
-
Anondita Medicare - Trading Window
-
Anondita Medicare - Updates
-
Anondita Medicare - Updates
-
Anondita Medicare - Updates
Key fundamentals
Evaluate the intrinsic value of Anondita Medicare Ltd stock
| Name | March-26 | March-25 | March-24 | ||
|---|---|---|---|---|---|
| Assets | 146.3046 | 55.7386 | 0.0962 | ||
| Liabilities | 146.3046 | 55.7386 | 0.0962 | ||
| Equity | 18.0866 | 13.2936 | 0.1 | ||
| Gross Profit | 39.3085 | 17.8846 | -0.0038 | ||
| Net Profit | 26.8201 | 10.7998 | -0.0038 | ||
| Cash From Operating Activities | 3.7887 | 6.0796 | -0.07 | ||
| NPM(%) | 24.01 | 17.84 | 0 | ||
| Revenue | 111.6962 | 60.5152 | 0 | ||
| Expenses | 72.3877 | 42.6306 | 0.0038 | ||
| ROE(%) | 24.69 | 9.94 | 0 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Anondita Medicare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 717.45 | 0.94 | 0.00 | 0.00 | -26.19 | 0.70 |
| Lotus Eye Hospital and Institute Ltd | 120.00 | -3.71 | 4000.00 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.18 | -1.37 | 23.16 | 0.00 | 15.96 | 0.00 |
| Astec Lifesciences Ltd | 805.55 | 6.27 | 0.00 | 0.00 | -363.14 | 0.00 |
Company Info
Our Company was incorporated as a public limited company with the name of "Anondita Medicare Limited" under the Companies Act, 2013 vide certificate of incorporation dated March 12, 2024, issued by Registrar of Companies, Central Registration Centre, bearing CIN U22193DL2024PLC428183. Prior to this, the business of the company was run by our current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare. Further, the entire business of M/s Anondita Healthcare, including all assets and liabilities, was transferred to our company, Anondita Medicare Limited vide Business Transfer Agreement dated April 01, 2024.KEY EVENTS AND MILESTONES:1999- The erstwhile proprietorship "M/s Health Care Products" was started by our current promoter, Mr. Anupam Ghosh for the packaging and sale of contraceptives and gloves.2013- The proprietorship was renamed to "M/s Anondita Healthcare".2024- Incorporation of our Company, Anondita Medicare Limited.- Takeover of M/s Anondita Healthcare by our company vide Business Takeover Agreement dated April 01, 2024.- Our company acquired 100% shareholding in "Anondita Healthcare and Rubber Products India Limited" vide a Share Purchase Agreement dated April 01, 2024, entered into between Anondita Healthcare and Rubber Products India Limited (Formerly Anondita Healthcare and Rubber Products India Private Limited) (First Party), Mr. Reshant Ghosh and Ms. Sonia Ghosh (Second Party) and our Company (Third Party).
Our Company was incorporated as a public limited company with the name of "Anondita Medicare Limited" under the Companies Act, 2013 vide certificate of incorporation dated March 12, 2024, issued by Registrar of Companies, Central Registration Centre, bearing CIN U22193DL2024PLC428183. Prior to this, the business of the company was run by our current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare. Further, the entire business of M/s Anondita Healthcare, including all assets and liabilities, was transferred to our company, Anondita Medicare Limited vide Business Transfer Agreement dated April 01, 2024.KEY EVENTS AND MILESTONES:1999- The erstwhile proprietorship "M/s Health Care Products" was started by our current promoter, Mr. Anupam Ghosh for the packaging and sale of contraceptives and gloves.2013- The proprietorship was renamed to "M/s Anondita Healthcare".2024- Incorporation of our Company, Anondita Medicare Limited.- Takeover of M/s Anondita Healthcare by our company vide Business Takeover Agreement dated April 01, 2024.- Our company acquired 100% shareholding in "Anondita Healthcare and Rubber Products India Limited" vide a Share Purchase Agreement dated April 01, 2024, entered into between Anondita Healthcare and Rubber Products India Limited (Formerly Anondita Healthcare and Rubber Products India Private Limited) (First Party), Mr. Reshant Ghosh and Ms. Sonia Ghosh (Second Party) and our Company (Third Party).
Read More
Parent Organisation
Anondita Medicare Ltd.
Founded
12/03/2024
Managing Director
Mr.Anupam Ghosh
NSE Symbol
ANONDITASM
FAQ
The current price of Anondita Medicare Ltd is
The 52-week high for Anondita Medicare Ltd is
The market capitalization of Anondita Medicare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Anondita Medicare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Anondita Medicare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anondita Medicare Ltd shares.
The CEO of Anondita Medicare Ltd is Mr.Anupam Ghosh, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
